Study of a new tablet for advanced breast, ovarian, and prostate cancers
Part of Cancer clinical trials.
This trial tests an experimental tablet called ZL-85FA for people with advanced breast, ovarian, fallopian tube, primary peritoneal, or prostate cancer. It aims to see if the drug is safe and effective, and may offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have advanced breast, ovarian, fallopian tube, primary peritoneal, or prostate cancer confirmed by biopsy or other tests.
- You are able to take care of yourself (ECOG score 0 or 1) and have a life expectancy of at least 12 weeks.
- Your organs are functioning well enough for the study.
- You have recovered from side effects of previous treatments (except hair loss or other non-serious issues).
- You agree to use effective birth control during the study and for 6 months after, if you or your partner can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new combination of two drugs (ZGGS18 and ZG005) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
This Phase 1 study tests XZB-0004 in adults with solid cancers to check safety and how the body responds to the drug. It may help doctors learn whether this treatment could be useful for certain tumor types, including non-small cell lung cancer.
This trial tests a new drug (DC05F01) for people with ovarian cancer that has come back after platinum treatment, or for those with other advanced solid tumors that haven't responded to standard therapies. It aims to see if the drug is safe and effective.
This trial tests an investigational pill for people with advanced or spreading solid tumors. It aims to see if the drug is safe and effective, and may be an option if standard treatments have not worked.
This trial tests a new oral drug (ZX-8177) for people with advanced solid tumors that have stopped responding to standard treatments or cannot be treated with standard options. The goal is to see if it is safe and helps control the disease.
This trial tests a new drug called ZL-6201 for people with sarcoma or certain solid tumors that have spread or cannot be removed. It aims to see if the drug is safe and helps shrink tumors.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.